Evidence map›Paper›PMID 28943328›Full record

ArticleCell host & microbe2017

O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection.

Marisel Sanchez, Stacey L Kolar, Sabrina Müller, Christopher N Reyes, Andrea J Wolf, Chihiro Ogawa, Rajat Singhania, Daniel D De Carvalho, Moshe Arditi, David M Underhill and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Conserved CD4Nature microbiology · 2026
    Article
  3. Article
  4. A dual role for PGLYRP1 in host defense and immune regulation duringbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. LinkingAntibiotics (Basel, Switzerland) · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Frontiers in cellular and infection microbiology · 2022
    Review
  15. Diverse Control Mechanisms of the Interleukin-1 Cytokine Family.Frontiers in cell and developmental biology · 2022
    Review
  16. Mechanism ofProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Evasion of Immunological Memory byFrontiers in immunology · 2021
    Review
  18. Review
  19. International journal of molecular sciences · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Marisel SanchezDivision of Pediatric Infectious Diseases, Cedars-Sinai Medical Center (CSMC), Los Angeles, CA 90048, USA; Research Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA.
Stacey L KolarDivision of Pediatric Infectious Diseases, Cedars-Sinai Medical Center (CSMC), Los Angeles, CA 90048, USA; Research Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA.
Sabrina MüllerDivision of Pediatric Infectious Diseases, Cedars-Sinai Medical Center (CSMC), Los Angeles, CA 90048, USA; Research Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA.
Christopher N ReyesResearch Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA.
Andrea J WolfResearch Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA.
Chihiro OgawaResearch Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA.
Rajat SinghaniaPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
Daniel D De CarvalhoPrincess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 2M9, Canada.
Moshe ArditiDivision of Pediatric Infectious Diseases, Cedars-Sinai Medical Center (CSMC), Los Angeles, CA 90048, USA; Research Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA.
David M UnderhillResearch Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA.
Gislâine A MartinsResearch Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA; Department of Medicine, Division of Gastroenterology, CSMC, Los Angeles, CA 90048, USA. Electronic address: martinsg@csmc.edu.
George Y LiuDivision of Pediatric Infectious Diseases, Cedars-Sinai Medical Center (CSMC), Los Angeles, CA 90048, USA; Research Division of Immunology, Department of Biomedical Sciences, CSMC, Los Angeles, CA 90048, USA; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, CSMC, Los Angeles, CA 90048, USA. Electronic address: george.liu@cshs.org.
Los Angeles Medical Center · USCedars-Sinai Medical Center · USPrincess Margaret Cancer Centre · CAUniversity Health Network · CA

Funding

Role of Blimp1 (Prdm1) in lung immune responses and toleranceR01AI103542 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI MARTINS, GISLAINE A · 2013 to 2025
$4.6M
Generating protective immunity to Staphylococcus aureusR01AI127406 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI LIU, GEORGE Y, MARTINS, GISLAINE A · 2017 to 2021
$2.8M
Regulation of effector T cell function by Blimp-1 in a murine model of colitisR21AI083948 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI MARTINS, GISLAINE A · 2009 to 2010
$447k
NIAID NIH HHS R01 AI103542NIAID NIH HHS R01 AI127406NIAID NIH HHS R21 AI083948
6 · The paper itself

Abstract

Humans do not usually develop effective immunity to Staphylococcus aureus reinfection. Using a murine model that mimics human infection, we show that lack of protective immunity to S. aureus systemic reinfection is associated with robust interleukin-10 (IL-10) production and impaired protective Th17 responses. In dendritic cell co-culture assays, priming with S. aureus promotes robust T cell proliferation, but limits Th cells polarization and production of IL-1β and other cytokines important for Th1 and Th17 differentiation. We show that O-acetylation of peptidoglycan, a mechanism utilized by S. aureus to block bacterial cell wall breakdown, limits the induction of pro-inflammatory signals required for optimal Th17 polarization. IL-10 deficiency in mice restores protective immunity to S. aureus infection, and adjuvancy with a staphylococcal peptidoglycan O-acetyltransferase mutant reduces IL-10, increases IL-1β, and promotes development of IL-17-dependent, Th cell-transferable protective immunity. Overall, our study suggests a mechanism whereby S. aureus modulates cytokines critical for induction of protective Th17 immunity.

Indexed as

AcetylationAcetyltransferasesAdaptive ImmunityAnimalsCoculture TechniquesDendritic CellsFemaleHumansInterleukin-10Interleukin-1betaMiceMice, Inbred BALB CMice, Inbred C57BLPeptidoglycanStaphylococcal InfectionsStaphylococcus aureusAcetyltransferasesIL10 protein, mouseInterleukin-10Interleukin-1betaPeptidoglycangroup A streptococcusIL-17immune evasionMRSApeptidoglycanreinfectionS. aureusStaphylococcus aureusTh17vaccine

Identifiers

PMID28943328
PMCPMC5679255
OpenAlexW2759237315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.